To further confirm that RANBP10 modulated c-Myc protein stability by targeting FBXW7, we treated the RANBP10-downregulation GBM cells with the highly effective shFBXW7 sequence (Supplementary Fig. S9C) [23]. This evidence concerns the gene RANBP10 and glioblastoma.